SCHEMBL3660558

SCHEMBL3660558

COC(=O)c1cc(C(C)=O)cc(-c2ccc(C)cc2N)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 6/20 0.42
HSD17B10 Q99714 5/20 0.42
MAPT P10636 5/20 0.42
KDM4E B2RXH2 4/20 0.42
HPGD P15428 3/20 0.42
MAPK1 P28482 2/20 0.42
LMNA P02545 1/20 0.42
ALOX15 P16050 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP46A1 Q9Y6A2 1/20 0.42
USP2 O75604 1/20 0.42
ATM Q13315 2/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
CNR2 P34972 1/20 0.39
TSHR P16473 1/20 0.38
ATAD2 Q6PL18 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8008715 0.94 TDP1 (0.49) TDP1ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL8005875 0.89 TDP1 (0.44) TDP1ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL7997686 0.86 KDM4E (0.46) TDP1ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL7996748 0.86 CA12 (0.51) TDP1ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL7945903 0.85 NOTUM (0.43) TDP1ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL8005894 0.83 SLC7A5 (0.43) TDP1ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL17707305 0.82 TDP1 (0.58) TDP1ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL8008718 0.81 KDM4E (0.46) KDM4EHPGDMAPK1NPC1RAB9A
SCHEMBL7950971 0.79 EGFR (0.39) TDP1ALDH1A1HSD17B10MAPTKDM4E
SCHEMBL19628228 0.77 HSD17B1 (0.54) TDP1ALDH1A1HSD17B10MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234989-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2010-10-06 EP disclosed
WO-2009077371-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-06-25 WO disclosed